89 related articles for article (PubMed ID: 3109329)
1. [Side effects and anti-cancer effects following intraperitoneal (ip) administration of mitomycin C (MMC)].
Takizawa K; Ino Y; Isono T; Sato M; Iguchi T; Takeda Y
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1877-83. PubMed ID: 3109329
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of intraperitoneal chemotherapeutic perfusion (IPCP) of mitomycin C (MMC) and intraperitoneal administration of cisplatin].
Yamashita S; Ito T; Kinashi N; Yakabe A
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2458-63. PubMed ID: 3113338
[TBL] [Abstract][Full Text] [Related]
3. [Serum levels of mitomycin C following a high-dose continuous hyperthermic peritoneal perfusion].
Hamazoe R; Koga S; Maeta M; Shimizu N; Sumi K; Oda M; Karino T; Yamane T; Kanayama H; Osaki Y
Gan To Kagaku Ryoho; 1984 Jan; 11(1):97-103. PubMed ID: 6421245
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.
Andersson M; Daugaard S; von der Maase H; Mouridsen HT
Cancer Treat Rep; 1986 Oct; 70(10):1181-6. PubMed ID: 3530444
[TBL] [Abstract][Full Text] [Related]
5. [Intraabdominal administration of MMC adsorbed on activated carbon for management of carcinomatous peritonitis].
Takahashi T; Hagiwara A; Ito T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1550-6. PubMed ID: 6433797
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative chemotherapy with carbon particles adsorbing mitomycin C for gastric cancer with peritoneal dissemination in rabbits.
Hagiwara A; Takahashi T; Ueda T; Lee R; Takeda M; Itoh T
Surgery; 1988 Nov; 104(5):874-81. PubMed ID: 3142071
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics and prophylactic effect of intraperitoneal administration of mitomycin C resulting in IC50 of gastric cancer].
Hiratsuka M; Furukawa H; Iwanaga T; Nagano H; Yasuda T; Masutani S; Oohigashi H; Kameyama M; Sasaki Y; Kabuto T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1541-5. PubMed ID: 2117888
[TBL] [Abstract][Full Text] [Related]
8. [Effects of the bronchial artery infusion of peplomycin (PEP) and mitomycin C (MMC) in lung cancer--comparison with single administration of PEP or MMC].
Yokoyama K; Takashima T; Nozaki M; Kaito S; Shimomura T; Takeuchi A; Kurokawa A
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1817-22. PubMed ID: 6192772
[TBL] [Abstract][Full Text] [Related]
9. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
10. Regional intra-arterial mitomycin C infusion in previously treated patients with metastatic colorectal cancer and concomitant measurement of serum drug level.
Tseng MH; Luch J; Mittelman A
Cancer Treat Rep; 1984 Nov; 68(11):1319-24. PubMed ID: 6437675
[TBL] [Abstract][Full Text] [Related]
11. [A clinical trial of a new mitomycin C derivative, KW-2083 (7-N-(p-hydroxyphenyl)-mitomycin C)].
Takahashi K; Yokoyama M; Takahashi H; Wakui A
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1787-93. PubMed ID: 4037809
[TBL] [Abstract][Full Text] [Related]
12. [Tolerance of intraoperative, intraperitoneal chemotherapy in advanced gynecologic malignancies].
Werner A; Diedrich K; Krebs D; Bode U; Musch E
Geburtshilfe Frauenheilkd; 1988 Aug; 48(8):574-8. PubMed ID: 3145897
[TBL] [Abstract][Full Text] [Related]
13. [Arterial infusion of microencapsulated mitomycin C for the treatment of locally recurrent carcinoma of the pelvic cavity].
Nemoto R; Kato T; Mori H; Chiba R; Shindo M; Kato H
Gan To Kagaku Ryoho; 1982 Apr; 9(4):646-51. PubMed ID: 6820903
[TBL] [Abstract][Full Text] [Related]
14. [Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
Nomura Y; Kanda K; Tashiro H; Hamada Y; Saeki K
Gan To Kagaku Ryoho; 1983 Mar; 10(3):824-8. PubMed ID: 6411002
[TBL] [Abstract][Full Text] [Related]
15. BCG (RIVM) versus mitomycin intravesical therapy in superficial bladder cancer. First results of randomized prospective trial.
DeBruyne FM; van der Meijden AP; Geboers AD; Franssen MP; van Leeuwen MJ; Steerenberg PA; de Jong WH; Ruitenberg JJ
Urology; 1988 Mar; 31(3 Suppl):20-5. PubMed ID: 3279698
[TBL] [Abstract][Full Text] [Related]
16. [A combination chemotherapy using mitomycin C, vincristine and cisplatin (MVP) for advanced cervical cancer].
Ikeda K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Usui N; Nakada H; Adachi K; Yamazaki H; Tada A
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):536-40. PubMed ID: 4004284
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of side effects of a combination chemotherapy of cisplatin and adriamycin in gynecological malignancies: comparison between intravenous and intraarterial administration].
Kawagoe K; Tsunoda H; Iijima S; Yokota H; Shigemitsu S
Gan To Kagaku Ryoho; 1984 Mar; 11(3):452-7. PubMed ID: 6538404
[TBL] [Abstract][Full Text] [Related]
18. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
Qu QL; Zhang YG; Yang LZ; Sun L
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):257-60. PubMed ID: 16875622
[TBL] [Abstract][Full Text] [Related]
19. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
20. [Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].
Hattori H; Mikuriya S; Mamiya T; Hatano K; Shiina T; Yamada T
Gan No Rinsho; 1988 Jun; 34(7):851-6. PubMed ID: 3135423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
